Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Chenguang Shen, Zhaoqin Wang, Fang Zhao, +24

JAMA

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

Qingxian Cai, Minghui Yang, Dongjing Liu, +23

Engineering

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Yan Wu, Feiran Wang, Chenguang Shen, +22

Science

Antibodies B38MedicineVaccine TargetViral PathogenesisImmunology +11

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

Yang Yang, Minghui Yang, Chenguang Shen, +19

Different Respiratory SpecimensViral RnasViral DiagnosticsCovid-19Diagnostic Test +14

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

Yang Yang, Chenguang Shen, Jinxiu Li, +22

Journal of Allergy and Clinical Immunology

Plasma Ip-10Disease ProgressionDisease SeverityCovid-19 PandemicImmunology +8

Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury

Yingxia Liu, Cong Zhang, Fengming Huang, +23

National Science Review

Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome

Yang Yang, Chenguang Shen, Jinxiu Li, +19

ImmunodeficienciesExuberant ElevationViral PathogenesisImmunologyMurray Score +17

Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection

Yang Yang, Minghui Yang, Jing Yuan, +18

The Innovation

Diagnostic VirologyWorldwide EpidemicViral PersistenceViral DiagnosticsEmerging Infectious Diseases +13

The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET

Chuang Liu, Luiza Mendonça, Yang Yang, +20

Structure

Virus StructureInactivated VirusesPrefusion SpikesEmerging Infectious DiseasesVaccine Surveillance +11

A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Yan Wu, Feiran Wang, Chenguang Shen, +22

Abstract Neutralizing AntibodiesNon-competing PairVaccine DevelopmentVaccine TargetViral Pathogenesis +13